Postnatal lifestyle programme prevents weight gain after gestational diabetes
Key takeaway:
A group-based lifestyle programme helped women with prior gestational diabetes avoid weight gain in the first year after giving birth, but engagement was low with only 10% attending all sessions.
Study at a glance
What was studied
Effectiveness of a postnatal lifestyle modification programme in women with prior GDM
Study type
Randomized Controlled Trials (RCTs)
duration
Medium-Term (3–12 mo)
Intervention
Lifestyle intervention for prediabetes
Outcomes
Body weight, Waist circumference, Fasting glucose, Depression score
Funding
Non-industry sponsored
Main effects
↓ Weight gain prevented: intervention group stable vs usual care +0.72 kg (difference −0.95 kg, p=0.04)
↔ Waist circumference: no significant difference between groups
↔ Fasting blood glucose: no significant difference between groups
Evidence Suggest
- The MAGDA lifestyle programme prevented postnatal weight gain in women with prior GDM, but did not improve other diabetes risk factors
- Engagement was very low: only 10% attended all sessions, and 34% attended none
- Loss to follow-up was high (27% intervention, 21% control), mainly due to subsequent pregnancies
Who this applies to
Women with prior gestational diabetes in their first postnatal year
Keep in Mind
The programme prevented weight gain but did not lead to weight loss — the benefit was mainly avoiding the weight gain seen in usual care
Between the Lines
- Low programme engagement: only 10% completed all sessions
- High attrition: 27% loss to follow-up in intervention group
- Baseline glucose profiles were near normal, limiting ability to detect changes
- Primary outcome (weight) significant but other primary outcomes (waist, glucose) non-significant
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Journal Reference
O'Reilly SL, Dunbar JA, Versace V, et al. Mothers after Gestational Diabetes in Australia (MAGDA): a randomised controlled trial of a postnatal diabetes prevention program. PLOS Med. 2016;13(7):e1002092. doi:10.1371/journal.pmed.1002092
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.
